Calliditas Therapeutics AB LC8A.DU Stock
35.8 EUR
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
Germany
Exchange
Dusseldorf
Market Cap
0 EUR
LOW - HIGH [24H]
35.6
-
36 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
0 EUR
Calliditas Therapeutics AB Price Chart
Calliditas Therapeutics AB LC8A.DU Financial and Trading Overview
| Calliditas Therapeutics AB stock price | 35.8 EUR |
| Previous Close | 15.9 EUR |
| Open | 16.3 EUR |
| Bid | 16.1 EUR x N/A |
| Ask | 16.8 EUR x N/A |
| Day's Range | 16.1 - 16.3 EUR |
| 52 Week Range | 11.3 - 23.2 EUR |
| Volume | 120 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LC8A.DU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Calliditas Therapeutics AB Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 23.2 EUR |
| 52 Week Low | 11.3 EUR |
| 50-Day Moving Average | 19.61 EUR |
| 200-Day Moving Average | 16.96 EUR |
LC8A.DU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Calliditas Therapeutics AB Stock
What is a current LC8A.DU stock price?
Calliditas Therapeutics AB LC8A.DU stock price today per share is 35.8 EUR.
How to purchase Calliditas Therapeutics AB stock?
You can buy LC8A.DU shares on the Dusseldorf exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Calliditas Therapeutics AB?
The stock symbol or ticker of Calliditas Therapeutics AB is LC8A.DU.
How many shares does Calliditas Therapeutics AB have in circulation?
The max supply of Calliditas Therapeutics AB shares is 0.
What is Calliditas Therapeutics AB Price to Earnings Ratio (PE Ratio)?
Calliditas Therapeutics AB PE Ratio is now.
What was Calliditas Therapeutics AB earnings per share over the trailing 12 months (TTM)?
Calliditas Therapeutics AB EPS is 0 EUR over the trailing 12 months.